In March, 23andMe said that it was looking to sell “substantially all of its assets” through a court-approved reorganization plan.

A cyberattack has caused several issues for patients and employees at Kettering Health facilities in the area. Kettering ...

Regeneron Pharmaceuticals will acquire embattled DNA testing company 23andMe in a $256 million court-supervised sale, ...

Bankrupt DNA testing company 23andMe was purchased Monday by biotechnology company Regeneron for $256 million. Both companies ...

Regeneron Pharmaceuticals is acquiring the assets of 23andMe for $256 million, excluding its Lemonaid Health business, as the ...

Regeneron Pharmaceuticals said it would acquire 23andMe, which filed for bankruptcy in March and would continue to offer ...

Salesforce is launching AI tools to up-skill employees and help them transition internally. Salesforce piloted its Career Connect service last year and 28% of users applied for jobs on the platform.

Regeneron Pharmaceuticals (NASDAQ:REGN – Free Report) had its price objective reduced by Truist Financial from $975.00 to $940.00 in a research note released on Wednesday,Benzinga reports.